Immunotherapy combinations versus TKIs for papillary renal cell carcinoma
Papillary renal cell carcinoma (pRCC) is the most common subtype [...]
Papillary renal cell carcinoma (pRCC) is the most common subtype [...]
A recent study looked at the use of a combination [...]
A recent real world study has found that giving immunotherapy [...]
Renal medullary carcinoma (RMC) is a rare and aggressive cancer [...]
The National Institute for Health and Care Excellence (NICE) has approved the [...]
The CheckMate-214 clinical trial was the first study to show [...]
This year’s American Society of Clinical Oncology Genitourinary Cancers (ASCO [...]
The final survival information from the phase 3 CLEAR study [...]
In 2009, Cesar Fuentes was first diagnosed with kidney cancer [...]
A recent clinical trial looked at a new anti-cancer medication [...]